Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a monotherapy versus untreated control in children with HBeAg-positive chronic hepatitis B
2011-002732-70Phase 3Unknown
- Sponsor
- Roche
- Start
- Aug 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of interferon alfa in Chronic Hepatitis B (CHB) (2 arms), sponsored by Roche. Primary endpoint: HBeAg seroconversion. Status: unknown.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2011-002732-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002732-70.